| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:1851-1857.)
© 2007 American Heart Association, Inc.
Coronary Heart Disease |
From the Department of Medicine, Montreal Heart Institute (C.B., P.L.L., J.G., J.L., R.I., J.C.T.), and the Montreal Heart Institute Coordinating Center (S.L.), Université de Montreal, Montreal, Quebec, Canada.
Correspondence to Dr Jean-Claude Tardif, Montreal Heart Institute, 5000 Belanger St, Montreal, Quebec, H1T 1C8, Canada. E-mail jean-claude.tardif{at}icm-mhi.org
Received July 31, 2006; accepted January 5, 2007.
Background The relative merits of quantitative coronary analysis (QCA) and intravascular ultrasound (IVUS) for the assessment of progression/regression in coronary artery disease are uncertain. To explore this subject further, we analyzed the angiographic and IVUS data derived from a contemporary clinical trial population.
Methods and Results We investigated the relationships between QCA and IVUS at single time points (n=525) and also for the changes over time (n=432). QCA and IVUS data underwent central laboratory analyses. Statistically significant correlations were observed between the QCA coronary artery score and the IVUS-derived lumen volume (r=0.65, P<0.0001) and total vessel volume (r=0.55, P<0.0001) and between the QCA cumulative coronary stenosis score and percent atheroma volume on IVUS (r=0.32, P<0.0001) at baseline for matched segments. A similar pattern of correlations was observed for global (all segments) QCA-derived and single-vessel IVUS-derived data. There were statistically significant but weak correlations between the changes over time in lumen dimensions on QCA and IVUS (P=0.005) and between the change in cumulative coronary stenosis score on QCA and percent atheroma volume on IVUS (r=0.14, P=0.01). Nevertheless, patients with and without angiographic progression had changes in plaque volume on IVUS of 9.13 and 0.20 mm3, respectively (P=0.028).
Conclusions QCA- and IVUS-derived measures of lumen dimensions are correlated at single time points and for changes over time. Although the change in percent atheroma volume is only weakly correlated with QCA changes as continuous variables, disease progression on QCA is associated with significant increases in plaque volume on IVUS compared with no angiographic progression.
This article has been cited by other articles:
![]() |
S. J. Lehman, C. L. Schlett, F. Bamberg, H. Lee, P. Donnelly, L. Shturman, M. F. Kriegel, T. J. Brady, and U. Hoffmann Assessment of Coronary Plaque Progression in Coronary Computed Tomography Angiography Using a Semiquantitative Score J. Am. Coll. Cardiol. Img., November 1, 2009; 2(11): 1262 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Tardif Angiotensin-converting enzyme inhibitors and atherosclerotic plaque: a key role in the cardiovascular protection of patients with coronary artery disease Eur. Heart J. Suppl., August 1, 2009; 11(suppl_E): E9 - E16. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aldrovandi, F. Cademartiri, A. Menozzi, F. Ugo, D. Lina, E. Maffei, A. Palumbo, M. Fusaro, G. Crisi, and D. Ardissino Evaluation of Coronary Atherosclerosis by Multislice Computed Tomography in Patients With Acute Myocardial Infarction and Without Significant Coronary Artery Stenosis: A Comparative Study With Quantitative Coronary Angiography Circ Cardiovasc Imaging, November 1, 2008; 1(3): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ballantyne, J. S. Raichlen, S. J. Nicholls, R. Erbel, J.-C. Tardif, S. J. Brener, V. A. Cain, S. E. Nissen, and for the ASTEROID Investigators Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden Circulation, May 13, 2008; 117(19): 2458 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Brown A Direct Comparison of Intravascular Ultrasound and Quantitative Coronary Arteriography: Implications for Measures of Atherosclerosis as Clinical Surrogates Circulation, April 10, 2007; 115(14): 1824 - 1826. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |